Filing Details
Jaguar Health, Inc. (NASDAQ:JAGX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 19, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:JAGX
Jaguar Health, Inc. (JAGX) Files Quarterly Report for Q0
Jaguar Health, Inc. (NASDAQ:JAGX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 19, 2026.
At publication ·
What changed
Jaguar Health, Inc. (NASDAQ:JAGX) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Jaguar Health, Inc. (NASDAQ: JAGX) filed its quarterly report (Form 10-Q) with the SEC on August 19, 2026.
- The company's stock trades at $0.92 per share with a market capitalization of $3.1 million.
- The 10-Q filing includes unaudited financial statements and management commentary on business performance, though specific revenue figures were not disclosed in this summary.
Market Context
Jaguar Health, Inc.'s stock currently trades at $0.92 with a market capitalization of $3.1M.
The 10-Q provides Jaguar Health, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Jaguar Health, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View JAGX Stock Page
Frequently Asked Questions
Where can I read JAGX's SEC filings?
Browse all filings on our JAGX SEC filings page.
What types of SEC filings does Jaguar Health, Inc. file?
Public companies like Jaguar Health, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.